Medrio Selected As Exclusive Data Management Solution for Leading Device and Diagnostic Sponsor

Medrio, a leading provider of decentralized and eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets, has been selected as the exclusive data management vendor for PAVmed Inc, a multi-product, commercial-stage medical technology company and its major subsidiary Lucid Diagnostics, Inc.

Recommended AI News: Dutch MedTech STENTiT Appoints Golo von Basum As Chief Operating Officer

Earlier this year PAVmed made the strategic decision to bring its data management in-house to gain full control of its studies. “We considered a number of EDC (electronic data capture) providers and chose Medrio because it has an excellent track record, a user-friendly system, and truly values the business of small to mid-sized organizations,” explained Randy Brown, Executive Vice President of Clinical Development of PAVmed. PAVmed and Lucid Diagnostics anticipate significant annual savings from this move to in-house data management.

Customer service was another important factor in PAVmed’s decision. “It was important for us to select a vendor who is responsive and supportive of their customers, no matter the size of the organization. Often small to mid-sized companies can get lost in the shuffle, but we felt Medrio would be best suited to handle a fast-growing company of our size,” explained Brown. Medrio’s customer service team boasts a 98% satisfaction rating along with 91% of all support requests being addressed in under 10 minutes.

Recommended AI News: Zeidler Group Announces Strategic Partnership With the Legal Innovation Lab Wales to Build AI Solutions for Legal Delivery

“Our solutions are designed with smart technology and AI (accuracy intelligence) to be flexible and agile enough that you can manage our tools without costly programming or third-party interventions – our intelligence technology does it for you. Delays can make or break a study, so the sooner you can get up and running, the better. With Medrio we can get your study up in less than two weeks—compared to the industry average of twelve. And we don’t just hand you the technology and walk away. We wrap you in support throughout your study, ensuring your success, while you maintain control over your data. It’s the Medrio differentiation and why our customer’s trust and partner with Medrio to grow their business,” detailed Fred Martin, Chief Product Officer of Medrio.arkets

“We’re proud to support PAVmed and Lucid Diagnostics and to continue our mission of building a healthier future,” said Martin.

Recommended AI News: New Physics Insights Enable Table-Top Hot Fusion